“This is a fundamental change in our understanding of how genes are controlled in the early embryo,” says Ken Zaret, director of the Institute for Regenerative Medicine and a professor of cell and developmental biology, “even if we can’t yet see all the potential clinical impacts.” Read the Penn Today article here.